02 Jul 2026

Telehealth

How Synapxe scaled HD+ from COVID to chronic care


Share this article

How Synapxe scaled HD+ from COVID to chronic care
From left to right: Yogaprakash Kumar (Senior Manager, Software Engineering & Enterprise Tooling), Rino Tan (Senior Manager, Patient Empowerment), Rizky Rukmana (Senior Manager, Software Engrg & Enterprise Tooling), Teh Kaixin (Assistant Lead Analyst, Clinical), and Angus Ong (Systems Analyst, Clinical)

Synapxe developed the Health Discovery (HD) platform during the COVID-19 pandemic to enable remote patient monitoring when off-the-shelf solutions could not meet Singapore’s operational and clinical requirements. The platform later evolved into Health Discovery+ (HD+), which is now used across polyclinics to support the remote monitoring of patients with chronic conditions such as diabetes and hypertension.

According to Synapxe’s Rino Tan, the development and of scaling HD+ nationally required close collaboration with healthcare partners to standardise workflows, train users, and balance consistency with local operational needs. Future improvements would focus on earlier clinical alignment, scalability, and change management.

View the full article here: https://www.frontier-enterprise.com/how-synapxe-scaled-hd-from-covid-to-chronic-care/

 

Related articles

X

By continuing to use and navigate this website, you consent to the use of cookies in accordance with our Privacy Policy.

Confirm